There are 383 resources available
Live Q&A / discussion
Session: ESMO Colloquium supported by Eli Lilly and Co. - One tumour, many faces: Optimising testing, targeting and monitoring oncogene-addicted NSCLC beyond EGFR
Resources:
Webcast
Concluding remarks
Presenter: Fernando Lopez-Rios
Session: ESMO Colloquium supported by Eli Lilly and Co. - One tumour, many faces: Optimising testing, targeting and monitoring oncogene-addicted NSCLC beyond EGFR
Resources:
Webcast
Co-mutations: Impact on current treatments and new combinations
Presenter: Pilar Garrido Lopez
Session: More targets, more drugs, more choices, more conflicts
Resources:
Slides
Webcast
Rebiopsy and cfDNA in a complex and changing landscape
Presenter: Nicola Normanno
Session: More targets, more drugs, more choices, more conflicts
Resources:
Slides
Webcast
Discussion
Session: More targets, more drugs, more choices, more conflicts
Resources:
Webcast
Introduction and first vote
Presenter: Kersti Oselin
Session: Surgery vs radiation therapy for stage III NSCLC in the context of immunotherapy
Resources:
Webcast
Radiotherapy perspective for resectable stage III non-small cell lung cancer in the era of immunotherapy
Presenter: Corinne Faivre-Finn
Session: Surgery vs radiation therapy for stage III NSCLC in the context of immunotherapy
Resources:
Slides
Webcast
Second vote and conclusions
Presenter: Kersti Oselin
Session: Surgery vs radiation therapy for stage III NSCLC in the context of immunotherapy
Resources:
Webcast
Relevance of real-world data in thoracic oncology
Presenter: Simon Ekman
Session: How to use real-world evidence for clinical decision making
Resources:
Slides
Webcast
Artificial intelligence to manage large set of data in thoracic oncology
Presenter: Marzia Del Re
Session: How to use real-world evidence for clinical decision making
Resources:
Slides
Webcast